294 related articles for article (PubMed ID: 28640909)
21. Induction of C chemokine XCL1 (lymphotactin/single C motif-1 alpha/activation-induced, T cell-derived and chemokine-related cytokine) expression by HIV-1 Tat protein.
Kim BO; Liu Y; Zhou BY; He JJ
J Immunol; 2004 Feb; 172(3):1888-95. PubMed ID: 14734774
[TBL] [Abstract][Full Text] [Related]
22. HIV-tat alters Connexin43 expression and trafficking in human astrocytes: role in NeuroAIDS.
Berman JW; Carvallo L; Buckner CM; Luers A; Prevedel L; Bennett MV; Eugenin EA
J Neuroinflammation; 2016 Mar; 13(1):54. PubMed ID: 26934876
[TBL] [Abstract][Full Text] [Related]
23. Tat predominantly associates with host promoter elements in HIV-1-infected T-cells - regulatory basis of transcriptional repression of c-Rel.
Dhamija N; Choudhary D; Ladha JS; Pillai B; Mitra D
FEBS J; 2015 Feb; 282(3):595-610. PubMed ID: 25472883
[TBL] [Abstract][Full Text] [Related]
24. Transient induction of cyclin T1 during human macrophage differentiation regulates human immunodeficiency virus type 1 Tat transactivation function.
Liou LY; Herrmann CH; Rice AP
J Virol; 2002 Nov; 76(21):10579-87. PubMed ID: 12368300
[TBL] [Abstract][Full Text] [Related]
25. HIV-1 Tat enhances purinergic P2Y4 receptor signaling to mediate inflammatory cytokine production and neuronal damage via PI3K/Akt and ERK MAPK pathways.
Zhou F; Liu X; Gao L; Zhou X; Cao Q; Niu L; Wang J; Zuo D; Li X; Yang Y; Hu M; Yu Y; Tang R; Lee BH; Choi BW; Wang Y; Izumiya Y; Xue M; Zheng K; Gao D
J Neuroinflammation; 2019 Apr; 16(1):71. PubMed ID: 30947729
[TBL] [Abstract][Full Text] [Related]
26. Human immunodeficiency virus type-1 protein Tat induces tumor necrosis factor-alpha-mediated neurotoxicity.
Buscemi L; Ramonet D; Geiger JD
Neurobiol Dis; 2007 Jun; 26(3):661-70. PubMed ID: 17451964
[TBL] [Abstract][Full Text] [Related]
27. Selective Vulnerability of Striatal D2 versus D1 Dopamine Receptor-Expressing Medium Spiny Neurons in HIV-1 Tat Transgenic Male Mice.
Schier CJ; Marks WD; Paris JJ; Barbour AJ; McLane VD; Maragos WF; McQuiston AR; Knapp PE; Hauser KF
J Neurosci; 2017 Jun; 37(23):5758-5769. PubMed ID: 28473642
[TBL] [Abstract][Full Text] [Related]
28. Central HIV-1 Tat exposure elevates anxiety and fear conditioned responses of male mice concurrent with altered mu-opioid receptor-mediated G-protein activation and β-arrestin 2 activity in the forebrain.
Hahn YK; Paris JJ; Lichtman AH; Hauser KF; Sim-Selley LJ; Selley DE; Knapp PE
Neurobiol Dis; 2016 Aug; 92(Pt B):124-36. PubMed ID: 26845176
[TBL] [Abstract][Full Text] [Related]
29. Caprine arthritis encephalitis virus dysregulates the expression of cytokines in macrophages.
Lechner F; Machado J; Bertoni G; Seow HF; Dobbelaere DA; Peterhans E
J Virol; 1997 Oct; 71(10):7488-97. PubMed ID: 9311828
[TBL] [Abstract][Full Text] [Related]
30. Effects of HIV-1 tat on secretion of TNF-α and IL-1β by U87 cells in AIDS patients with or without AIDS dementia complex.
Zhao L; Pu SS; Gao WH; Chi YY; Wen HL; Wang ZY; Song YY; Yu XJ
Biomed Environ Sci; 2014 Feb; 27(2):111-7. PubMed ID: 24625401
[TBL] [Abstract][Full Text] [Related]
31. Monocytes-derived macrophages mediated stable expression of human brain-derived neurotrophic factor, a novel therapeutic strategy for neuroAIDS.
Tong J; Buch S; Yao H; Wu C; Tong HI; Wang Y; Lu Y
PLoS One; 2014; 9(2):e82030. PubMed ID: 24505242
[TBL] [Abstract][Full Text] [Related]
32. Dopamine and its receptors play a role in the modulation of CCR5 expression in innate immune cells following exposure to Methamphetamine: Implications to HIV infection.
Basova L; Najera JA; Bortell N; Wang D; Moya R; Lindsey A; Semenova S; Ellis RJ; Marcondes MCG
PLoS One; 2018; 13(6):e0199861. PubMed ID: 29944719
[TBL] [Abstract][Full Text] [Related]
33. HIV-1 Tat alters neuronal autophagy by modulating autophagosome fusion to the lysosome: implications for HIV-associated neurocognitive disorders.
Fields J; Dumaop W; Eleuteri S; Campos S; Serger E; Trejo M; Kosberg K; Adame A; Spencer B; Rockenstein E; He JJ; Masliah E
J Neurosci; 2015 Feb; 35(5):1921-38. PubMed ID: 25653352
[TBL] [Abstract][Full Text] [Related]
34. HIV Tat acts on endogenous retroviruses of the W family and this occurs via Toll-like receptor 4: inference for neuroAIDS.
Uleri E; Mei A; Mameli G; Poddighe L; Serra C; Dolei A
AIDS; 2014 Nov; 28(18):2659-70. PubMed ID: 25250834
[TBL] [Abstract][Full Text] [Related]
35. Signatures of HIV-1 subtype B and C Tat proteins and their effects in the neuropathogenesis of HIV-associated neurocognitive impairments.
Williams ME; Zulu SS; Stein DJ; Joska JA; Naudé PJW
Neurobiol Dis; 2020 Mar; 136():104701. PubMed ID: 31837421
[TBL] [Abstract][Full Text] [Related]
36. HIV tat and neurotoxicity.
King JE; Eugenin EA; Buckner CM; Berman JW
Microbes Infect; 2006 Apr; 8(5):1347-57. PubMed ID: 16697675
[TBL] [Abstract][Full Text] [Related]
37. Measuring the Uptake and Transactivation Function of HIV-1 Tat Protein in a Trans-cellular Cocultivation Setup.
Ruiz AP; Prasad VR
Methods Mol Biol; 2016; 1354():353-66. PubMed ID: 26714724
[TBL] [Abstract][Full Text] [Related]
38. Immunomodulatory Role of Complement Proteins in the Neuropathology Associated with Opiate Abuse and HIV-1 Co-Morbidity.
Mahajan SD; Aalinkeel R; Parikh NU; Jacob A; Cwiklinski K; Sandhu P; Le K; Loftus AW; Schwartz SA; Quigg RJ; Alexander JJ
Immunol Invest; 2017 Nov; 46(8):816-832. PubMed ID: 29058550
[TBL] [Abstract][Full Text] [Related]
39. Molecular mechanism(s) involved in the synergistic induction of CXCL10 by human immunodeficiency virus type 1 Tat and interferon-gamma in macrophages.
Dhillon N; Zhu X; Peng F; Yao H; Williams R; Qiu J; Callen S; Ladner AO; Buch S
J Neurovirol; 2008 May; 14(3):196-204. PubMed ID: 18569454
[TBL] [Abstract][Full Text] [Related]
40. HIV-1 Tat interactions with p300 and PCAF transcriptional coactivators inhibit histone acetylation and neurotrophin signaling through CREB.
Wong K; Sharma A; Awasthi S; Matlock EF; Rogers L; Van Lint C; Skiest DJ; Burns DK; Harrod R
J Biol Chem; 2005 Mar; 280(10):9390-9. PubMed ID: 15611041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
